Recombinant MT-ND3 is a full-length, His-tagged protein derived from the mitochondrial genome of Hylobates lar (white-handed gibbon). It is a core subunit of Complex I (NADH:ubiquinone oxidoreductase), which catalyzes electron transfer from NADH to ubiquinone in the mitochondrial electron transport chain . This recombinant variant is expressed in E. coli systems for research applications, enabling studies on mitochondrial dysfunction and associated diseases .
Recombinant MT-ND3 is produced in E. coli systems, followed by affinity chromatography using His-tag purification. Key steps include:
Reconstitution: Lyophilized powder is resuspended in sterile water (0.1–1.0 mg/mL) with 5–50% glycerol for stability .
Yield: Typically 0.5–2 mg/L culture, depending on expression conditions .
Quality Control: Verified via SDS-PAGE and mass spectrometry .
MT-ND3 is essential for catalytic activity of Complex I; its absence disrupts assembly of the 950-kDa holoenzyme .
The A47T mutation (caused by 10197G>A in mtDNA) impairs hydrophobic interactions, leading to Leigh syndrome and mitochondrial encephalopathies .
Transmembrane Helices: Critical for proton channel formation .
Ubiquinone-Binding Site: Facilitates electron transfer from FMN to ubiquinone .
Recombinant Hylobates lar NADH-ubiquinone oxidoreductase chain 3 (MT-ND3) is a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). It catalyzes electron transfer from NADH through the respiratory chain, utilizing ubiquinone as an electron acceptor. MT-ND3 is essential for the catalytic activity of Complex I.
MT-ND3 (NADH-ubiquinone oxidoreductase chain 3) is a protein encoded by the mitochondrial gene MT-ND3. It functions as a core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I). This complex is critical for cellular respiration, as it catalyzes the transfer of electrons from NADH to ubiquinone (coenzyme Q), which is a mobile carrier in the inner mitochondrial membrane . This electron transfer is coupled with the translocation of approximately four protons across the inner mitochondrial membrane into the intermembrane space, contributing to the establishment of a proton gradient that drives ATP synthesis2.
Within Complex I, MT-ND3 works alongside approximately 19 other membrane-bound proteins. The complex contains proteins with iron-sulfur clusters and a flavin group, which facilitate electron transfer. After receiving electrons, the mobile electron carrier ubiquinone diffuses away to transfer its electrons to the next complex in the respiratory chain2.
Hylobates lar (white-handed gibbon) MT-ND3 has been sequenced as part of mitochondrial genome studies, with the complete mtDNA sequence available in GenBank (accession number X99256) . Comparative analyses of the MT-ND3 region across primate species reveal evolutionary relationships and species-specific adaptations.
Studies examining the mitochondrial ND3-ND4 region in gibbons have shown significant sequence variation across the Hylobatidae family. Within-genus uncorrected sequence divergence means in the Hylobates genus (which includes H. lar) are approximately 0.059970 (range: 0.00000-0.09156), indicating considerable genetic diversity . This variation reflects the evolutionary history of gibbons and their adaptation to different ecological niches.
The phylogenetic analysis of MT-ND3 and related mitochondrial genes has been instrumental in resolving the species-level relationships among hylobatids, confirming the monophyly of the four recognized genera: Nomascus, Bunopithecus, Symphalangus, and Hylobates .
Recombinant expression of Hylobates lar MT-ND3 presents several challenges due to its hydrophobic nature and mitochondrial origin. Based on established methodologies for similar mitochondrial proteins, the following approaches are recommended:
Expression Systems Selection:
Bacterial systems (E. coli): Suitable for initial expression attempts due to rapid growth and high yield, but may require optimization to address inclusion body formation
Yeast systems (S. cerevisiae, P. pastoris): Provide eukaryotic processing capabilities while maintaining relatively high yields
Baculovirus-insect cell systems: Often preferred for mitochondrial membrane proteins due to proper folding and post-translational modifications
Mammalian cell systems: Most physiologically relevant but typically lower yields
Optimization Strategies:
Codon optimization for the expression host
Fusion with solubility tags (MBP, SUMO, Trx)
Expression at lower temperatures (16-20°C)
Use of specialized E. coli strains (C41, C43) designed for membrane protein expression
Purification Approaches:
Detergent-based extraction (DDM, LMNG, or digitonin)
Affinity chromatography using engineered tags
Size exclusion chromatography for final polishing
Based on protocols used for similar mitochondrial proteins, a two-step purification process combining affinity chromatography with size exclusion often yields the purest protein preparations.
Studying the structure-function relationship of Hylobates lar MT-ND3 requires an integrated approach combining structural biology, biochemistry, and functional analyses:
Structural Analysis Approaches:
Cryo-electron microscopy (cryo-EM) has become the method of choice for Complex I structural studies, enabling visualization of the protein in near-native conditions
X-ray crystallography, though challenging with membrane proteins, can provide high-resolution structural information when successful
NMR spectroscopy for specific domains or peptide segments of MT-ND3
In silico modeling based on homologous structures from other species
Functional Characterization Methods:
Site-directed mutagenesis to identify critical residues
Complex I activity assays measuring NADH:ubiquinone oxidoreductase activity
Proton pumping assays using reconstituted proteoliposomes
Measurements of ROS production to assess electron leakage
Integration with Whole Complex Studies:
Reconstitution of MT-ND3 with other Complex I subunits
Assembly studies using pulse-chase experiments
Blue native PAGE analysis to examine complex formation
Interaction studies using crosslinking mass spectrometry
A comprehensive understanding requires examining MT-ND3 both in isolation and within the context of the entire Complex I, with particular attention to interfaces with other subunits and involvement in proton translocation pathways.
MT-ND3 mutations in humans have been associated with various mitochondrial disorders, including Leigh syndrome, MELAS, and sensorimotor axonal polyneuropathy . Studying homologous mutations in Hylobates lar MT-ND3 can provide valuable insights into disease mechanisms and potential therapeutic approaches.
Comparative analysis of pathogenic mutations can reveal:
Conservation of Critical Residues:
Highly conserved residues across species that, when mutated, lead to similar biochemical defects
Species-specific differences that may explain variable disease expression
Functional Consequences:
Impact on Complex I assembly and stability
Effects on electron transport efficiency
Changes in proton pumping capacity
Increased reactive oxygen species (ROS) production
Cellular Adaptations:
Compensatory mechanisms that may mitigate the effects of mutations
Tissue-specific responses to mitochondrial dysfunction
A notable example comes from human studies where a novel mutation m.10372A>G in MT-ND3 was identified in a patient with adult-onset sensorimotor axonal polyneuropathy. Muscle tissue analysis revealed ragged red fibers, paracrystalline inclusions, significant reduction in Complex I respiratory chain activity, and decreased ATP production for all substrates used by Complex I . Similar functional studies in Hylobates lar models could help identify conserved pathogenic mechanisms.
Optimizing heterologous expression systems for functional studies of recombinant Hylobates lar MT-ND3 requires addressing several challenges specific to mitochondrial membrane proteins:
Expression System Selection and Optimization:
| Expression System | Advantages | Limitations | Optimization Strategies |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid | Lacks post-translational modifications, forms inclusion bodies | Low temperature induction (16-20°C), specialized strains (C41/C43), fusion tags |
| Yeast | Eukaryotic processing, moderate yield | Differences in membrane composition | Codon optimization, inducible promoters, cultivation parameter adjustment |
| Insect cells | Good folding, post-translational modifications | Longer production time, higher cost | Baculovirus titer optimization, harvest time determination |
| Mammalian cells | Most native-like conditions | Lowest yield, highest cost | Stable cell line generation, bioreactor cultivation |
Functional Reconstitution Approaches:
Incorporation into nanodiscs or liposomes to mimic native membrane environment
Co-expression with interacting partners from Complex I
Development of cell-free expression systems with direct incorporation into artificial membranes
Activity Assessment Methods:
Spectrophotometric assays measuring NADH oxidation
Electron transfer measurements using artificial electron acceptors
Membrane potential measurements in reconstituted systems
Oxygen consumption rates in whole cells or isolated mitochondria
Validation Strategies:
Comparison with native Complex I isolated from Hylobates lar tissue
Complementation studies in Complex I-deficient cell lines
Response to known Complex I inhibitors and activators
The most successful approaches typically combine mammalian expression systems for structural studies with bacterial systems for mutagenesis and initial functional characterization, followed by validation in more physiologically relevant models.
Understanding the interactions between MT-ND3 and other Complex I subunits is crucial for elucidating the assembly, stability, and function of this important respiratory complex. Several complementary methodologies can be employed:
Physical Interaction Studies:
Cross-linking mass spectrometry (XL-MS) to identify amino acid residues in close proximity
Co-immunoprecipitation with antibodies specific to MT-ND3 or other subunits
Surface plasmon resonance (SPR) or isothermal titration calorimetry (ITC) for quantitative binding parameters
FRET or BRET assays for proximity detection in living cells
Assembly Pathway Analysis:
Pulse-chase labeling to track incorporation of MT-ND3 into Complex I
Blue native PAGE combined with western blotting to visualize assembly intermediates
Protein import assays in isolated mitochondria
Time-course analysis of complex formation using inducible expression systems
Structural Biology Approaches:
Cryo-EM of intact Complex I at various stages of assembly
Hydrogen/deuterium exchange mass spectrometry to map interaction surfaces
Computational docking and molecular dynamics simulations
NMR studies of isotopically labeled domains
Functional Interaction Assessment:
Mutagenesis of putative interaction sites followed by activity assays
Suppressor mutation analysis to identify compensatory changes
Construction of chimeric proteins to map functional interaction domains
Thermal stability assays to assess complex integrity
The integration of these approaches can generate a comprehensive understanding of how MT-ND3 contributes to Complex I architecture and function, potentially revealing species-specific adaptations in Hylobates lar compared to other primates.
Heteroplasmy—the presence of both wild-type and mutant mitochondrial DNA within cells—is a critical factor in determining the phenotypic expression of mitochondrial mutations. Studies involving primates, including Hylobates species, provide valuable insights into this phenomenon.
Heteroplasmy Quantification Methods:
Last-cycle hot PCR is a validated method for quantifying heteroplasmic levels of mutated mtDNA in different tissues
Next-generation sequencing allows for high-throughput and highly sensitive detection of low-level heteroplasmy
Digital droplet PCR provides absolute quantification of mutant versus wild-type mtDNA
Pyrosequencing offers rapid quantification with moderate sensitivity
Tissue-Specific Heteroplasmy Patterns:
Human studies have demonstrated that heteroplasmy levels can vary significantly between tissues
In a study of a novel MT-ND3 mutation causing sensorimotor axonal polyneuropathy, cultured myoblasts did not carry the mutation that was present in skeletal muscle, and consequently showed normal respiratory chain activity
This tissue-specific distribution of mutant mtDNA contributes to the varied clinical manifestations of mitochondrial disorders
Threshold Effects:
Biochemical defects typically manifest when the proportion of mutant mtDNA exceeds a tissue-specific threshold
For MT-ND3 mutations, this threshold may vary depending on the specific mutation and tissue energy requirements
Tissues with high energy demands, such as muscle and nervous tissue, generally display symptoms at lower heteroplasmy levels
Research Applications:
Studying heteroplasmy dynamics in Hylobates lar could provide evolutionary insights into mitochondrial selection pressures
Comparing heteroplasmy thresholds across primate species may reveal species-specific adaptations in mitochondrial function
Such comparative studies could inform the development of therapeutic approaches for human mitochondrial disorders
Understanding heteroplasmy is essential for interpreting experimental results involving MT-ND3 mutations and for developing accurate disease models.
Research on Hylobates lar MT-ND3 and other mitochondrial genes has significant implications for gibbon conservation efforts. Gibbons are among the most endangered primates, threatened by habitat loss, fragmentation, hunting, and illegal trade . MT-ND3 research contributes to conservation in several ways:
Taxonomic Clarification and Evolutionary History:
Mitochondrial gene analysis, including MT-ND3, has helped establish the phylogenetic relationships among hylobatids, confirming four distinct genera: Nomascus, Bunopithecus, Symphalangus, and Hylobates
This taxonomic clarity is essential for developing species-specific conservation strategies
Understanding the evolutionary history of gibbons provides context for current distribution patterns and genetic diversity
Population Genetics and Diversity Assessment:
MT-ND3 sequences can be used as markers to assess genetic diversity within populations
Within-genus uncorrected sequence divergence in Hylobates has been measured at approximately 0.059970 (range: 0.00000-0.09156) , indicating considerable genetic diversity that should be preserved
Molecular data helps identify genetically distinct populations that require targeted conservation efforts
Health Monitoring and Disease Susceptibility:
Understanding the function of MT-ND3 and potential impact of mutations provides insight into energy metabolism in gibbons
This knowledge can inform veterinary care for captive populations and rehabilitation efforts
Comparative studies may reveal species-specific adaptations that influence habitat requirements
Forensic Applications:
MT-ND3 sequences can be used to identify the species origin of gibbon specimens in illegal wildlife trade
This supports law enforcement efforts to combat poaching and trafficking of these endangered primates
Conservation strategies informed by molecular genetic data, including MT-ND3 research, are more likely to succeed in preserving the genetic diversity and evolutionary potential of gibbon populations.
Investigating the role of MT-ND3 in oxidative stress response is crucial for understanding mitochondrial dysfunction in both normal aging and pathological conditions. The following techniques offer powerful approaches:
Real-time ROS Detection Methods:
Fluorescent probes (DCF-DA, MitoSOX Red) for live-cell imaging of ROS production
Genetically encoded redox sensors (roGFP, HyPer) for compartment-specific measurements
Electron paramagnetic resonance (EPR) spectroscopy for direct detection of free radicals
Protein carbonylation assays to measure oxidative damage to proteins
Genetic Manipulation Approaches:
CRISPR/Cas9-mediated introduction of specific MT-ND3 mutations
Cybrid cell models containing different levels of mutant mtDNA
Inducible expression systems to control MT-ND3 variant expression
RNA interference to modulate expression of nuclear-encoded Complex I assembly factors
Biochemical Analysis Techniques:
Isolated mitochondria respiration measurements using Seahorse XF analyzers
Complex I enzyme activity assays under varying oxidative conditions
Redox state analysis of NAD+/NADH and glutathione pools
Lipid peroxidation assessment using TBARS or 4-HNE immunodetection
Systems Biology Approaches:
Transcriptomics to identify changes in stress response pathways
Proteomics to detect post-translational modifications related to oxidative stress
Metabolomics focusing on redox-sensitive metabolites
Integration of multiple omics data to model cellular responses
These techniques, applied to Hylobates lar MT-ND3 variants, can reveal the specific contribution of this subunit to ROS generation and management, potentially identifying species-specific adaptations in oxidative stress handling that could inform human disease research.
Comparative studies between human and Hylobates lar MT-ND3 provide valuable insights into mitochondrial disease mechanisms, offering evolutionary perspectives that can enhance our understanding of pathogenicity:
Evolutionary Conservation Analysis:
Identification of highly conserved residues that, when mutated, are likely to cause dysfunction
Recognition of species-specific variations that may represent adaptive changes
Understanding functional constraints on MT-ND3 across primate evolution
Structure-Function Comparisons:
Mapping disease-causing mutations onto structural models of both human and Hylobates lar MT-ND3
Identifying differences in amino acid composition at key functional sites
Analyzing how species-specific variations might influence Complex I assembly and function
Physiological Adaptation Studies:
Investigating differences in mitochondrial function that might reflect adaptations to different environmental niches
Exploring potential correlations between MT-ND3 sequence variations and metabolic requirements
Examining how differences in nuclear-encoded Complex I subunits interact with MT-ND3 variants
Experimental Disease Models:
Development of cell lines expressing Hylobates lar MT-ND3 variants in human nuclear backgrounds
Introduction of human disease-associated mutations into Hylobates lar MT-ND3 to assess functional impacts
Comparative analysis of heteroplasmy thresholds for biochemical defects across species
A case study highlighting the value of such comparative approaches involves a novel m.10372A>G mutation in human MT-ND3, which causes sensorimotor axonal polyneuropathy . By examining whether equivalent mutations in Hylobates lar MT-ND3 produce similar biochemical defects, researchers can gain insights into the evolutionary conservation of mitochondrial disease mechanisms and potentially identify species-specific protective factors.
MT-ND3 mutations have been implicated in neurological disorders, including a reported case of sensorimotor axonal polyneuropathy . Investigating the role of MT-ND3 in neurodegenerative processes requires specialized approaches:
Neuronal Model Systems:
iPSC-derived neurons carrying MT-ND3 mutations
Primary neuronal cultures from transgenic animal models
Organoid models incorporating MT-ND3 variants
Ex vivo brain slice cultures for acute manipulation of mitochondrial function
Functional Assessments in Neuronal Context:
Electrophysiological recordings to assess neuronal activity
Calcium imaging to evaluate intracellular calcium dynamics
Axonal transport assays to examine mitochondrial trafficking
Neurite outgrowth and synaptogenesis quantification
Neurodegeneration-Specific Analyses:
Assessment of mitochondrial membrane potential in neurites
Quantification of synaptic mitochondria morphology and function
Examination of mitochondrial quality control mechanisms
Analysis of neuron-specific metabolic requirements and adaptations
Translational Research Approaches:
Correlation of MT-ND3 variant effects with clinical neurological findings
Development of neuroprotective strategies targeting Complex I dysfunction
Biomarker identification for early detection of neurodegeneration
Therapeutic approaches to enhance mitochondrial function in neurons
These methodologies should be applied with consideration of the unique aspects of neuronal biology, including:
High energy demands and reliance on oxidative phosphorylation
Complex morphology requiring mitochondrial trafficking over long distances
Specialized synaptic compartments with local energy needs
Vulnerability to excitotoxicity and oxidative stress
The findings from such studies could have significant implications for understanding and treating mitochondrial neuropathies and potentially broader neurodegenerative conditions.
The future of Hylobates lar MT-ND3 research will be shaped by several emerging technologies that promise to enhance our understanding of mitochondrial function and evolution:
Advanced Imaging Technologies:
Cryo-electron tomography for visualizing Complex I in situ
Super-resolution microscopy techniques for tracking single Complex I molecules
Label-free imaging methods for non-invasive mitochondrial assessment
Correlative light and electron microscopy for structure-function studies
Genome Editing and Synthetic Biology:
Base editing and prime editing for precise mtDNA modification
Mitochondria-targeted nucleases for heteroplasmy shifting
Synthetic organelle systems to reconstitute minimal functional units
Allotopic expression of mitochondrial genes from the nucleus
Single-Cell and Spatial Technologies:
Single-cell transcriptomics and proteomics to examine cell-to-cell variability
Spatial metabolomics to map metabolic activity within tissues
Multi-omics integration at single-cell resolution
In situ sequencing for heteroplasmy mapping within tissues
Computational and AI Approaches:
Deep learning for predicting mutational impacts on protein function
Molecular dynamics simulations with enhanced sampling techniques
Systems biology modeling of mitochondrial energy metabolism
Comparative genomics across primates for evolutionary insights
These technologies will enable researchers to address fundamental questions about MT-ND3 function, evolution, and role in disease with unprecedented precision and contextual understanding, potentially leading to novel therapeutic strategies for mitochondrial disorders.
Studying mitochondrially encoded proteins like MT-ND3 presents unique technical challenges that require specialized approaches:
Genetic Manipulation Strategies:
Cybrid technology to introduce mitochondrial mutations into controlled nuclear backgrounds
Mitochondria-targeted nucleases (mitoTALENs, mitoCRISPR) for specific mtDNA editing
Allotopic expression of recoded MT-ND3 from the nucleus with mitochondrial targeting
RNA import strategies to introduce modified mRNAs into mitochondria
Protein Expression and Purification:
Cell-free expression systems with membrane-mimetic environments
Co-expression with interacting partners to stabilize the protein
Native purification of entire Complex I followed by subunit isolation
Development of amphipathic environments that maintain protein structure
Functional Assessment Innovations:
Label-free activity assays to avoid interference with protein function
Real-time monitoring of multiple parameters simultaneously
In-organello translation systems to study protein synthesis
Microfluidic platforms for high-throughput functional screening
Structural Biology Advancements:
Novel membrane mimetics that better represent the mitochondrial inner membrane
Integration of computational prediction with experimental validation
Fragment-based approaches for difficult-to-crystallize regions
Time-resolved structural studies to capture dynamic states
By addressing these technical challenges, researchers can overcome the traditional barriers to studying mitochondrially encoded proteins, leading to more comprehensive insights into MT-ND3 function in both normal physiology and disease states across primate species, including Hylobates lar.